Delay in Covaxin's approval, WHO awaits crucial info - Until Covaxin gets an emergency use authorisation from WHO it cannot get widespread acceptability as a safe and effective vaccine around the world.
Bharat Biotech recently said it submitted all data pertaining to Covaxin to the WHO for emergency use and is awaiting feedback from the global health watchdog.
The technical advisory group of the World Health Organisation (WHO) will meet on October 26 to consider the emergency use listing (EUL) for Bharat Biotech s Covaxin, Chief Scientist at WHO, Soumya Swaminathan said on Sunday.